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A B S T R A C T   
Background: The evaluation of 24 h urinary oxalate excretion is the gold standard for diagnosing hyperoxaluria in 
patients with recurrent urolithiasis. However, 24 h urine sample collection is cumbersome. Therefore we aim to 
see if oxalate to creatinine ratio in random urine sample can be used as an alternative. 
Materials and methods: A cross-sectional study was conducted at Section of Chemical Pathology, Department of 
Pathology and Laboratory Medicine Aga Khan University Karachi from 1st February to December 31, 2019. A 
total of 62 adult patients, 18–60 years of age with history of kidney stones presenting to the clinical laboratory 
for 24 h urine oxalate estimation were invited to participate in the study after informed consent. Clinical details 
were recorded on a structured questionnaire and patients were guided to submit 24 h urine and a random spot 
urine sample. Urinary oxalate was measured on Micro lab 300 using a kit based on oxalate oxidase principle by 
Trinity Biotech plc, Wicklow, Ireland following standard operating procedures. Urinary creatinine was measured 
on ADVIA 1800 by Siemens, US using kinetic Jaffe reaction according to the manufacturer’s instructions. The 
data was analyzed on SPSS. 
Results: In a period of ten months, a total of 62 subjects were recruited; mean age was 32.4 ± 2.6 years. Males 
were 49 (79.0%) and females were 13 (20.9%). Correlation was found to be (r = 0.289) by Spearman correlation 
(p value < 0.005). Taking 24 h urinary oxalate as gold standard the sensitivity, specificity, positive predictive 
value and negative predictive value of spot oxalate to creatinine ratio was 83.3%, 17.8%, 9.8% and 90.9% 
respectively. 
Conclusion: The random spot urine test cannot replace the 24 h urinary oxalate estimation in patients with 
urolithiasis.   
Oxalate is a metabolic end product of glyoxalate metabolism 
excreted by the kidneys. It has a high affinity for calcium and form 
calcium oxalate crystals, which has low solubility and are typically 
deposited within the renal interstitium and tubular cells [1]. Hyper-
oxaluria may present with recurrent kidney stones to end stage renal 
disease and systemic oxalosis due to reduced urinary excretion when 
glomerular filtration rate (GFR) falls below 30–40 mL/min per 1.73 m2 
[2]. 
The evaluation of 24 h urinary oxalate excretion is considered gold 
standard for diagnosing hyperoxaluria in patients with recurrent 
urolithiasis [3]. However, 24 h urine sample collection is cumbersome 
and often inaccurate due to factors such as the patient missing a urine 
pass in the collection jar, the quantity of acid added preservative to the 
container or the possibility of other liquid being added to the container 
instead of urine to fulfill the volume requirement [4]. In addition, a 
study by Parks et al. showed that principle stone risk factors and dietary 
and environmental factors vary enough in 24 h urine samples making a 
24 h urinary sample inadequate for correct diagnosis [5]. It is proposed 
that a single specimen is not an ideal predictor of hyperoxaluria and the 
final mean of two 24 h urine samples should be taken for diagnosis. 
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rolithotomy; FTIR, Fourier Transform Infrared Spectroscopy. 
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Considering these limitations 24 h urinary oxalate is usually not prac-
tical to screen for hyperoxaluria. A second morning random urine 
sample, for oxalate to creatinine ratio has been proposed as an alter-
native [6,7]. 
Oxalate: creatinine ratio is considered a better index of oxalate 
excretion as it avoids error from an inaccurately timed collection and 
ease of calculation from a spot urine sample. This is an advantage 
especially for children and severely ill patients. A correlation ‘r’ of 0.352 
between 24 h urinary oxalate and spot urinary oxalate to creatinine ratio 
was shown in the study by Hong et al. (p value 0.028). And found that 
the two paired measurements did not show good agreement, based on 
the estimated “limit of agreement” by the Bland and Altman test of 
agreement [4]. The reason for the disagreement was believed to be due 
to the time-to-time variations in the urinary oxalate concentrations that 
vary according to the body hydration status, diurnal circadian rhythm 
and period after food intake. Seema L et al. from India reported signif-
icantly high oxalate: creatinine ratio in stone formers compared to 
control group (p < 0.05) on spot urine samples and spot urinary samples 
are recommended spot urinary samples as screening procedure for 
hyperoxaluria [8]. 
The relationship of spot and 24 h urine oxalate has not been studied 
in Pakistani population, where the frequency of undifferentiated 
hyperoxaluria is seen in up to 43% of paediatric stone formers [9]. We 
therefore studied the relationship between 24 h urinary oxalate excre-
tion and spot urine oxalate to creatinine ratio to determine its clinical 
utility against the use of 24 h urinary oxalate estimation which is the 
standard practice. 
1. Material & methods 
A cross-sectional study was conducted at Section of Chemical Pa-
thology, Department of Pathology and Laboratory Medicine, Aga Khan 
University, Karachi from 1st February to December 31, 2019. Adult 
patients with history of kidney stones presenting at the Clinical Labo-
ratory for 24 h urine oxalate estimation were included in the study. 
Debilitated or bed ridden patients and patients with renal failure or end 
stage renal disease, in whom urinary oxalate is no longer an indicator of 
disease status were excluded from the study. Study was approved by 
ethical review committee of Aga Khan University Hospital. Patients after 
informed consent, were guided to submit a spot urine sample. Clinical 
details were recorded on a structured questionnaire by the principal 
investigator. 
24 h urine samples were collected in a jar having thymol, which is 
routinely added to limit bacterial growth and hence guard against citrate 
degradation. Spot urine samples were collected in red top container 
without any added preservatives. The specimen were transported to the 
laboratory within the 12 h of collection of 24 h urinary specimen. 
Volume of 24 h urine was measured in liters. After mixing of the 
urinary sample to overcome effects of sedimentation, a 6 mL aliquot was 
made and HCl was added to avoid the precipitation of oxalate crystals in 
every sample. Specimen was stored at − 20C till further analysis. 
Urinary oxalate was measured on Micro lab 300 using a kit based on 
oxalate oxidase principle by Trinity Biotech plc. Wick low, Ireland 
following standard operating procedures. Urinary creatinine was 
measured on ADVIA 1800 by Siemens, US using kinetic Jaffe reaction. 
Both normal and abnormal quality control materials were run with 
every batch of oxalate and creatinine analysis in urine to validate the 
results. In addition, external proficiency testing of urinary oxalate was 
conducted by College of American Pathologists (CAP). 
The cut-offs for 24 h oxalate excretion was 502 ųmol/24 h for males 
and 353 ųmol/24 h for females. The cut-offs for spot oxalate: creatinine 
ratio was 33 ųmol/mmol for males and 45 ųmol/mmol for females [10]. 
1.1. Statistical analysis 
Data was entered and analyzed in to SPSS 22 version. To check the 
normality of the data Shapiro Wilk test was applied. Descriptive statis-
tics were given as mean, median and interquartile range (IQR). Fre-
quency and percentages were calculated for gender distribution, 
recurrent stone, and family history of urolithiasis respectively. Spear-
man’s correlation was applied because data was non-parametric. 
Concordance between 24 h and spot oxalate excretion was run and 
Cohen’s kappa values were calculated. P-value ≤0.05 was taken as 
statistically significant. 
2. Results 
In a period of ten months, a total of 62 subjects with urolithiasis were 
recruited. Mean age was 32.4 ± 2.6 years. Males were 49 (79.0%) and 
females were 13 (20.9%). 
Majority of the subjects had ureteric stones (62.5%), followed by 
renal and bladder stones in 28.2% & 6.3% respectively. Twenty subjects 
had undergone surgery for stone removal (9 had extracorporeal shock 
wave lithotripsy, 11 had PCNL). However, the stone analysis was 
available in 7 cases (35%) only, which in all cases consist of calcium 
oxalate crystals as the primary constituent. The stone analysis was done 
by Fourier-transform infrared spectroscopy (FTIR). 
The most common presenting complaint was flank pain (79.7%) 
followed by nausea and vomiting (53.1%) and dysuria (23.4%). The risk 
factors pertaining to urolithiasis in the study subjects were decreased 
water consumption (67.2%), previous history of stones (21.9%), family 
history of stones (20.3%) and smoking (10.9%). 
Table 1 shows the overall and gender wise distribution of median 
(IQR) of 24 h urinary oxalate and spot oxalate to creatinine ratio with 
distribution of subjects with high oxalate excretion. Six subjects (5 males 
and 1 female) had high 24 h urine oxalate excretion, of which 5 had high 
spot oxalate to creatinine ratio. Spot oxalate: creatinine ratio was high 
among 51 patients (42 males and 9 females). Table 2 shows the com-
parison of 24 h urinary oxalate and spot oxalate to creatinine ratio in 7 
subjects with calcium oxalate crystals on stone analysis. Only 2 subjects 
had hyperoxaluria in contrast to all subjects with high spot oxalate to 
creatinine ratio. Taking 24 h urinary oxalate as gold standard the 
sensitivity, specificity, positive predictive value and negative predictive 
value of spot oxalate to creatinine ratio was 83.3%, 17.8%, 9.8% and 
90.9% respectively in diagnosing hyperoxaluria. 
Poor concordance was seen between 24 h oxalate excretion and spot 
oxalate to creatinine ratio in the subjects studied with a kappa value 
0.037. Poor correlation (r = 0.289) was found between 24 h urine ox-
alate and oxalate to creatinine ratio by applying Spearmans correlation. 
However, it was statistically significant (p value < 0.005), as shown in 
Fig. 1. 
Table 1 
Comparison of overall and elevated median (IQR) of urinary oxalate excretion in 
24-h & spot urine samples in both genders (n = 62).   
Median 
(IQR) 
No of Patients with High Oxalate Value in Each 
Group 
Male (n = 49) Female (n = 13) 
N (%) Median 
(IQR) 
N (%) Median 
(IQR) 
24 h urine oxalate 
in umol/24 h 
217 
(138.2) 
5 
(10.2%) 
592.8 
(189.2) 
1 
(7.6%) 
370.5* 
Spot urine oxalate 
to creatinine 
ratio in ųmol/ 
mmol 
63.3 
(45.6) 
42 
(85.7%) 
77.5 
(48.5) 
9 
(69.2%) 
69.3 
(39.9) 
For 24 h urine oxalate excretion cutoff used of 502 μmol/24 h was used for 
labelling Hyperoxaluria in males while in females a cutoff 353 μmol/24 h was 
applied. For spot urine oxalate to creatinine ratio a cutoff of 33 ųmol/mmol was 
used for identifying Hyperoxaluria in males while in females a cutoff 45 ųmol/ 
mmol was applied [9]. 
*IQR not calculated. 
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3. Discussion 
To the best of our knowledge, this is the first study about relationship 
between 24 h urine oxalate and spot oxalate to creatinine ratio in Pak-
istani population. Several studies have assessed the prospect of using 
spot urine or timed, urine samples for metabolic evaluation in patients 
with urolithiasis. Studies have reported good correlations between the 
24 h urine calcium and phosphate excretions and their corresponding 
spot urine calcium/creatinine and phosphate/creatinine ratios but there 
is not much literature on oxalate comparison in 24 h and spot sample in 
stone formers [8,10]. Some investigators have argued on the association 
between the 24 h urinary excretion and their corresponding spot urine 
creatinine ratio as a good indicator for using the spot urine sample in 
replacement to the 24 h urine sample. Yet Hoi Hong investigated the 
correlations and agreements between the solute/creatinine ratios from 
the 24-h and early morning spot urine samples for metabolic evaluation 
in stone-formers. The investigators reported poor correlation (r = 0.352) 
of 24 h oxalate excretion and spot urinary oxalate: creatinine ratio. They 
concluded that morning spot urine is not appropriate and cannot replace 
the 24-h urine collection in the evaluation of urinary metabolic abnor-
malities in stone-formers [4]. However, the correlation coefficient may 
not be the appropriate statistical test in assessing whether measurements 
from the two methods agree with each other as in our study [11]. A high 
correlation does not represent a good agreement between the two 
related measurements because the measurement with a larger range of 
true quantity in the sample will have a higher correlation, in which 
solute/creatinine ratio of a single urinary parameter can vary widely in 
range, thus ensuring a significant correlation. The reason for the 
disagreement is believed to be mainly due to the time-to-time variations 
in the urinary solute concentrations (urinary volume) that vary ac-
cording to the body hydration status, diurnal circadian rhythm and di-
etary patterns affecting oxalate excretion [12]. 
Primary hyperoxaluria or oxalosis is associated with recurrent renal 
stone formation that usually begins in childhood [11]. Therefore in 
patients with recurrent renal calculi or unexplained renal failure pri-
mary hyperoxaluria must be considered as an important, though rare 
diagnosis. Prompt diagnosis and appropriate management are crucial. 
For screening and accurate identification of primary hereditary hyper-
oxaluria or secondary hyperoxaluria it is essential to quantitate urinary 
oxalate [13]. As daily urine collection for determining oxalate excretion 
is cumbersome we studied the relation of daily oxalate excretion with 
oxalate: creatinine ratio in randomly collected urine sample. In the stone 
formers studied, only six patients out of the total sixty two patients 
showed elevated urinary oxalate excretion however the spot oxalate: 
creatinine ratio was high in 51 patients. Poor concordance was seen 
between 24 h oxalate excretion and spot oxalate to creatinine ratio in the 
subjects studied with a kappa value 0.037. Considering twenty four 
urinary oxalate excretion as the gold standard the study shows hyper-
oxaluria in 9.6% (n = 6) of the patients studied. 
3.1. Limitations 
The limitations in our study included single centre study and small 
sample size. Also the dietary habits, environmental conditions, body 
composition were not assessed. 
4. Conclusion 
In conclusion, the random spot urine test cannot replace the 24 h 
urinary oxalate estimation in patients with urolithiasis. Further studies 
should be conducted taking diet, water intake, drugs and comorbidity 
into consideration and understand the influence of diet on 24 h urine 
oxalate and spot urine oxalate to creatinine ratio. 
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Table 2 
Comparison of 24 h urinary oxalate and spot urine oxalate to creatinine ratio in 
patients tested by stone analysis (n = 7).  
S⋅NO* Age 
(Years) 
Gender 24 h urine 
oxalate (umol/ 
24 h) 
Spot urine Ox/ 
Cr (ųmol/ 
mmol) 
Family 
History 
1 40 Male 539.2 94.7 Present 
2 29 Male 513 109 Absent 
3 58 Male 228 64.5 Absent 
4 26 Male 305.5 139.1 Absent 
5 23 Male 216.6 83.3 Absent 
6 19 Male 148.2 89 Present 
7 22 Male 114 83.6 Absent 
*All subjects had calcium oxalate crystals on stone analysis. 
Fig. 1. Relation of Spot oxalate to creatinine ratio to 24 h oxalate excre-
tionCorrelation between the two tests was assessed by Spearman’s correlation 
coefficient (r = 0.289). 
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